StockTipsArenaBeta

BUY Aurobindo Pharma — Aditya Agarwal, Coheron Brokers

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byAditya Agarwal, Coheron BrokersHorizon: NA (inferred Swing (≤2wk))9 Jun 2026via Business Today

Entry₹1,420Stated
Target₹1,550
Total upside +9.15% (call closed)
Stop loss₹1,395-1.76% risk
Exit₹1,39515 Jun 2026, 2:15 pm
Stop-loss hit-1.76%
Follow Aditya Agarwal for new calls(30% target hit, 23 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:24 pm IST
4 supporting0 opposing
Supports the BUY call (4)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·10 Jun · 4d ago

Aurobindo Pharma Ltd has received final US FDA approval for its Tafacitinib tablets in 5 mg and 10 mg strengths. This approval is a significant regulatory milestone for the company's pharmaceutical pr

BSE · Company Update·4 Jun · 1w ago

(opens in new tab)

Aurobindo Pharma Ltd is issuing a press release regarding the inauguration of Theranym, a large-scale biologics contract manufacturing facility in India.

BSE · Company Update·3 Jun · 2w ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·6 Apr · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Aditya Agarwal, Coheron Brokers

Every call and its outcome